255 related articles for article (PubMed ID: 17171498)
1. Mitochondrial DNA mutations in differentiated thyroid cancer with respect to the age factor.
Witte J; Lehmann S; Wulfert M; Yang Q; Röher HD
World J Surg; 2007 Jan; 31(1):51-9. PubMed ID: 17171498
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in papillary and follicular thyroid carcinoma: their implications for cancer staging.
Lang BH; Lo CY; Chan WF; Lam KY; Wan KY
Ann Surg Oncol; 2007 Feb; 14(2):730-8. PubMed ID: 17103065
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathologic features and BRAF(V600E) mutation analysis in cutaneous metastases from well-differentiated thyroid carcinomas.
Erickson LA; Jin L; Nakamura N; Bridges AG; Markovic SN; Lloyd RV
Cancer; 2007 May; 109(10):1965-71. PubMed ID: 17387744
[TBL] [Abstract][Full Text] [Related]
4. Mutational Analysis in Pediatric Thyroid Cancer and Correlations with Age, Ethnicity, and Clinical Presentation.
Nikita ME; Jiang W; Cheng SM; Hantash FM; McPhaul MJ; Newbury RO; Phillips SA; Reitz RE; Waldman FM; Newfield RS
Thyroid; 2016 Feb; 26(2):227-34. PubMed ID: 26649796
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors of papillary and follicular thyroid cancer: differences in an iodine-replete endemic goiter region.
Passler C; Scheuba C; Prager G; Kaczirek K; Kaserer K; Zettinig G; Niederle B
Endocr Relat Cancer; 2004 Mar; 11(1):131-9. PubMed ID: 15027890
[TBL] [Abstract][Full Text] [Related]
6. Can the microRNA signature distinguish between thyroid tumors of uncertain malignant potential and other well-differentiated tumors of the thyroid gland?
Lassalle S; Hofman V; Ilie M; Bonnetaud C; Puisségur MP; Brest P; Loubatier C; Guevara N; Bordone O; Cardinaud B; Lebrigand K; Rios G; Santini J; Franc B; Mari B; Al Ghuzlan A; Vielh P; Barbry P; Hofman P
Endocr Relat Cancer; 2011 Oct; 18(5):579-94. PubMed ID: 21778212
[TBL] [Abstract][Full Text] [Related]
7. Papillary thyroid carcinoma tall cell variant shares accumulation of mitochondria, mitochondrial DNA mutations, and loss of oxidative phosphorylation complex I integrity with oncocytic tumors.
Tsybrovskyy O; De Luise M; de Biase D; Caporali L; Fiorini C; Gasparre G; Carelli V; Hackl D; Imamovic L; Haim S; Sobrinho-Simões M; Tallini G
J Pathol Clin Res; 2022 Mar; 8(2):155-168. PubMed ID: 34792302
[TBL] [Abstract][Full Text] [Related]
8. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
[TBL] [Abstract][Full Text] [Related]
9. Disease-free survival in papillary and follicular thyroid carcinoma. Comparison between UICC 5th and 7th classifications of T stage, and the prognostic value of primary tumour size.
Meixner M; Hellmich M; Dietlein M; Kobe C; Schicha H; Schmidt M
Nuklearmedizin; 2013; 52(3):71-80. PubMed ID: 23483137
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of c-RET expression in papillary thyroid carcinomas from the Korean population.
Lee S; Hong SW; Moon WC; Oh MR; Lee JK; Ahn CW; Cha BS; Kim KR; Lee HC; Lim SK
Thyroid; 2005 Mar; 15(3):259-66. PubMed ID: 15785245
[TBL] [Abstract][Full Text] [Related]
11. Anaplastic carcinoma of the thyroid arising more often from follicular carcinoma than papillary carcinoma.
Wang HM; Huang YW; Huang JS; Wang CH; Kok VC; Hung CM; Chen HM; Tzen CY
Ann Surg Oncol; 2007 Oct; 14(10):3011-8. PubMed ID: 17638058
[TBL] [Abstract][Full Text] [Related]
12. Detection and prognostic relevance of cytokeratin 20 in differentiated and anaplastic thyroid carcinomas by RT-PCR.
Schmitz-Winnenthal FH; Weckauf H; Haufe S; Hinz U; Z'graggen K; Klar E; Büchler MW; Weber T
Surgery; 2003 Dec; 134(6):964-71; discussion 971-2. PubMed ID: 14668729
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma.
Machens A; Holzhausen HJ; Dralle H
Cancer; 2005 Jun; 103(11):2269-73. PubMed ID: 15856429
[TBL] [Abstract][Full Text] [Related]
14. Clear Cell Change in Thyroid Carcinoma: A Clinicopathologic and Molecular Study with Identification of Variable Genetic Anomalies.
Cipriani NA; Agarwal S; Dias-Santagata D; Faquin WC; Sadow PM
Thyroid; 2017 Jun; 27(6):819-824. PubMed ID: 28293986
[TBL] [Abstract][Full Text] [Related]
15. Risk-profile and outcome of small papillary and follicular thyroid carcinomas (Rahbar K; Hutzenlaub V; Fischer RJ; Schober O; Riemann B
Nuklearmedizin; 2008; 47(5):188-93. PubMed ID: 18852924
[TBL] [Abstract][Full Text] [Related]
16. The age- and shorter telomere-dependent TERT promoter mutation in follicular thyroid cell-derived carcinomas.
Liu T; Wang N; Cao J; Sofiadis A; Dinets A; Zedenius J; Larsson C; Xu D
Oncogene; 2014 Oct; 33(42):4978-84. PubMed ID: 24141777
[TBL] [Abstract][Full Text] [Related]
17. Comparison of survival rates between papillary and follicular thyroid carcinomas among 36,725 patients.
Oyer SL; Fritsch VA; Lentsch EJ
Ann Otol Rhinol Laryngol; 2014 Feb; 123(2):94-100. PubMed ID: 24574464
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor enhances proliferation, migration, and invasion of follicular and papillary thyroid cancer in vitro and in vivo.
Hoelting T; Siperstein AE; Clark OH; Duh QY
J Clin Endocrinol Metab; 1994 Aug; 79(2):401-8. PubMed ID: 8045955
[TBL] [Abstract][Full Text] [Related]
19. High frequency of somatic mitochondrial DNA mutations in human thyroid carcinomas and complex I respiratory defect in thyroid cancer cell lines.
Abu-Amero KK; Alzahrani AS; Zou M; Shi Y
Oncogene; 2005 Feb; 24(8):1455-60. PubMed ID: 15608681
[TBL] [Abstract][Full Text] [Related]
20. Differentiated thyroid carcinoma: comparison between papillary and follicular carcinoma in a single institute.
Chow SM; Law SC; Au SK; Leung TW; Chan PT; Mendenhall WM; Lau WH
Head Neck; 2002 Jul; 24(7):670-7. PubMed ID: 12112541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
